Literature DB >> 28007143

Genetics: Implications for Prevention and Management of Coronary Artery Disease.

Themistocles L Assimes1, Robert Roberts2.   

Abstract

An exciting new era has dawned for the prevention and management of coronary artery disease (CAD) utilizing genetic risk variants. The recent identification of over 60 susceptibility loci for CAD confirms not only the importance of established risk factors, but also the existence of many novel causal pathways that are expected to improve our understanding of the genetic basis of CAD and facilitate the development of new therapeutic agents over time. Concurrently, Mendelian randomization studies have provided intriguing insights on the causal relationship between CAD-related traits, and highlight the potential benefits of long-term modifications of risk factors. Last, genetic risk scores of CAD may serve not only as prognostic, but also as predictive markers, and carry the potential to considerably improve the delivery of established prevention strategies. This review will summarize the evolution and discovery of genetic risk variants for CAD and their current and future clinical applications.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mendelian randomization; genetic variation; risk scores; sequencing

Mesh:

Year:  2016        PMID: 28007143     DOI: 10.1016/j.jacc.2016.10.039

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  32 in total

Review 1.  Genome-Wide Association Studies of Coronary Artery Disease: Recent Progress and Challenges Ahead.

Authors:  Shoa L Clarke; Themistocles L Assimes
Journal:  Curr Atheroscler Rep       Date:  2018-07-18       Impact factor: 5.113

2.  Highlighting Residual Atherosclerotic Cardiovascular Disease Risk.

Authors:  Yunosuke Matsuura; Jenny E Kanter; Karin E Bornfeldt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

Review 3.  Genetic Risk Prediction for Primary and Secondary Prevention of Atherosclerotic Cardiovascular Disease: an Update.

Authors:  Christopher Labos; George Thanassoulis
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

4.  Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?

Authors:  Jesse D Ortendahl; Allison L Diamant; Peter P Toth; Dasha Cherepanov; Amanda L Harmon; Michael S Broder
Journal:  Clin Cardiol       Date:  2018-11-28       Impact factor: 2.882

Review 5.  Genetic Risk, Adherence to a Healthy Lifestyle, and Ischemic Heart Disease.

Authors:  Thomas F Whayne; Sibu P Saha
Journal:  Curr Cardiol Rep       Date:  2019-01-10       Impact factor: 2.931

Review 6.  How Genomics Is Personalizing the Management of Dyslipidemia and Cardiovascular Disease Prevention.

Authors:  Lane B Benes; Daniel J Brandt; Eric J Brandt; Michael H Davidson
Journal:  Curr Cardiol Rep       Date:  2018-10-17       Impact factor: 2.931

Review 7.  Leveraging information from genetic risk scores of coronary atherosclerosis.

Authors:  Themistocles L Assimes; Elias L Salfati; Liana C Del Gobbo
Journal:  Curr Opin Lipidol       Date:  2017-04       Impact factor: 4.776

8.  Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents implantation.

Authors:  Yanqiang Wu; Xianghua Fu
Journal:  J Clin Lab Anal       Date:  2018-09-17       Impact factor: 2.352

Review 9.  A Less than Provocative Approach for the Primary Prevention of CAD.

Authors:  Robert Roberts; Jacques Fair
Journal:  J Cardiovasc Transl Res       Date:  2021-06-14       Impact factor: 4.132

10.  Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population.

Authors:  Maria Isabel Mendonça; Eva Henriques; Sofia Borges; Ana Célia Sousa; Andreia Pereira; Marina Santos; Margarida Temtem; Sónia Freitas; Joel Monteiro; João Adriano Sousa; Ricardo Rodrigues; Graça Guerra; Roberto Palma Dos Reis
Journal:  Genet Mol Biol       Date:  2021-06-11       Impact factor: 1.771

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.